Andrew E Price, MD

Insurance Information

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Publications

Scopus h-index:16

Article:25

Review Article:6

Comment/Debate:2

Letter:3

Recent Artifacts

• Effect of a Protocol to Reduce Radiographic Imaging in Pediatric Patients with Suspected Fractures
• A history of eponym usage in hip and pelvis radiography part 1: the paediatric hip
• Result of modified Outerbridge-Kashiwagi procedure for elbow flexion contractures in brachial plexus birth injury
• The Use of Botulinum Toxin Injection for Brachial Plexus Birth Injuries: A Systematic Review of the Literature
• Complications in Surgery for Brachial Plexus Birth Injury: Avoidance and Treatment
• Intravenous Glomus Tumor Masquerading as Lateral Antebrachial Cutaneous Neuroma
• Lower extremity nerve trauma
• Reoperation for failed shoulder reconstruction following brachial plexus birth injury
• Subscapularis slide correction of the shoulder internal rotation contracture after brachial plexus birth injury: Technique and outcomes
• Outcome after tendon transfers to restore wrist extension in children with brachial plexus birth injuries

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Price did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.